NewsFDA investigates possible increased risk of death with lymphoma drugAuthor:Victoria SternPublish date: February 4, 2022Clinical trial findings of “possible increased risk of death” associated with the drug umbralisib for CLL prompted the FDA to announce reevaluation...Read More
ArticleTreating metastatic TNBC: Where are we now?Author:Victoria SternPublish date: April 8, 2021New antibody-drug conjugates are a step in the right direction, but the key to developing effective therapies hin...Read More
